Asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis are
representative chronic respiratory diseases (CRDs). Although they differ in terms of disease …

Exacerbations are among the major factors that may affect the natural history of chronic
obstructive pulmonary disease (COPD). The aim was to investigate the clinical …

Clinical phenotyping is currently used to guide pharmacological treatment decisions in
chronic obstructive pulmonary disease (COPD), a personalized approach to care. Precision …

Treatment of COPD should reflect the complexity and heterogeneity of the disease and be
tailored to individual patients. Major goals of COPD treatment are symptom reduction and …

Rationale: The efficacy of intensified combination therapy with inhaled corticosteroids (ICS)
and long-acting β2-agonists (LABA) at the onset of upper respiratory tract infection (URTI) …

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are important
causes of hospital admission and mortality. Pneumonia is a major contributor to …

Background In the recent years, a variety of bronchoscopic lung volume reduction (BLVR)
procedures have emerged that may provide a treatment option to participants suffering from …

Pheno-/endotyping chronic obstructive pulmonary disease (COPD) is really important
because it provides patients with precise and personalized medicine. The central concept of …

Background Inhaled long-acting bronchodilators are the mainstay of pharmacotherapy for
chronic obstructive pulmonary disease (COPD). Both the twice-daily long-acting β2 …

Rationale To assess the treatment progression during the 24 months following a formal
diagnosis of chronic obstructive pulmonary disease (COPD) in the UK primary care setting …